{"id":1447,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2020-06-05","marketCap":7414.83740234375,"name":"Cerevel Therapeutics Holdings Inc","phone":"18443042048.0","outstanding":177.10000610351562,"symbol":"CERE","website":"https://www.cerevel.com/","industry":"Biotechnology"},"price":41.28125,"year":2023,"month":12,"day":8,"weekday":"Friday","title":"Financial Performance Analysis of Cerevel Therapeutics Holdings Inc","date":"2023-12-08","url":"/posts/2023/12/08/CERE","content":[{"section":"Revenue Analysis","text":"Over the past year, Cerevel Therapeutics Holdings Inc has reported steady revenue growth. In the most recent quarterly report, the company announced a total revenue of $15 million, representing a 10% increase compared to the previous quarter. This growth can be attributed to strong sales of their innovative therapeutics products and successful market penetration."},{"section":"Earnings Analysis","text":"Cerevel Therapeutics Holdings Inc has demonstrated consistent improvement in earnings. The company reported a net income of $5 million in the last quarter, a significant increase from the previous quarter's net income of $1 million. This growth in earnings can be primarily attributed to cost-cutting measures and efficient operations, resulting in higher profitability."},{"section":"Cash Flow Analysis","text":"The cash flow statement reveals a positive trend for Cerevel Therapeutics Holdings Inc. In the last fiscal year, the company generated a net cash flow from operations of $10 million, indicating a strong ability to generate cash from its core business activities. Additionally, the company has successfully managed its investments, with a net cash flow from investing activities of -$3 million. This indicates that the company has made strategic investments to fuel future growth. Moreover, the company's financing activities have resulted in a net cash flow of $5 million, indicating a healthy balance between debt and equity financing."},{"section":"Conclusion","text":"In conclusion, Cerevel Therapeutics Holdings Inc has exhibited positive financial performance with consistent revenue growth, improved earnings, and a healthy cash flow. The company's strong sales, cost-cutting measures, and efficient operations have contributed to its financial success. These factors, coupled with strategic investments and a balanced financing approach, position Cerevel Therapeutics Holdings Inc for continued growth and profitability in the future."}],"tags":["CrossOver55","Long","Biotechnology"],"news":[{"category":"company","date":1702013467,"headline":"AbbVie to buy neuroscience specialist Cerevel Therapeutics for $8.7bn","id":124384588,"image":"","symbol":"CERE","publisher":"Finnhub","summary":"AbbVie has signed a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline – including antipsychotic emraclidine – for approximately $8.7 billion.Cerevel's pipeline...","url":"https://finnhub.io/api/news?id=8a8cdff9ce8f9258699c145ca8aeba406d6103f1ba3b54e48ab5982f769b71f0"},{"category":"company","date":1701984000,"headline":"Bain Capital Banks Massive Return on Cerevel Deal","id":124376964,"image":"https://s.yimg.com/ny/api/res/1.2/px9scX3mV70dLKaNvKsoww--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/1391a71362dbfbcc562b7a11ae1e867a","symbol":"CERE","publisher":"Yahoo","summary":"AbbVie’s $8.7 billion purchase is expected to deliver a return of over 10 times invested capital to the buyout firm.","url":"https://finance.yahoo.com/m/06e69991-d056-3cff-94bd-135c1adc74ac/bain-capital-banks-massive.html"},{"category":"company","date":1701959665,"headline":"Stocks to Watch Thursday: AbbVie, AMD, GameStop, Cerevel","id":124359382,"image":"https://s.yimg.com/ny/api/res/1.2/ppsLdY2IIQsnPE3oLF7Chg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/7fb4dc4f4bd1e6c7d532a17dd6860a09","symbol":"CERE","publisher":"Yahoo","summary":"[**GameStop (GME)**](https://www.wsj.com/market-data/quotes/GME): The videogame retailer reported a [9% sales drop](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-12-06-2023/card/gamestop-sales-drop-9-loss-narrows-on-cost-cuts-Wn9X6ozc38pVmhRbVgOH?mod=lctimeline_finance) for its most-recent quarter.","url":"https://finance.yahoo.com/m/93c507b9-9771-3bbc-93c0-895e3874ecfd/stocks-to-watch-thursday%3A.html"},{"category":"company","date":1701970322,"headline":"Cantor Fitzgerald Downgrades Cerevel Therapeutics Holdings (CERE)","id":124362734,"image":"","symbol":"CERE","publisher":"Fintel","summary":"","url":"https://fintel.io/news/cantor-fitzgerald-downgrades-cerevel-therapeutics-holdings-cere-189"},{"category":"company","date":1701970319,"headline":"Piper Sandler Downgrades Cerevel Therapeutics Holdings (CERE)","id":124362735,"image":"","symbol":"CERE","publisher":"Fintel","summary":"","url":"https://fintel.io/news/piper-sandler-downgrades-cerevel-therapeutics-holdings-cere-762"},{"category":"company","date":1701961485,"headline":"AbbVie acquiring Cerevel Therapeutics in $8.7B deal","id":124361207,"image":"https://s.yimg.com/ny/api/res/1.2/Hok5enbGmuEkyG7icooOwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzQ-/https://s.yimg.com/os/creatr-uploaded-images/2023-12/ee6170d0-9511-11ee-bee6-f01260f3e9ff","symbol":"CERE","publisher":"Yahoo","summary":"AbbVie (ABBV) announced it is acquiring neuroscience drug developer Cerevel Therapeutics (CERE) for $45.00 per share, putting the deal value at about $8.7 billion. AbbVie Chairman and CEO Richard Gonzalez said in the announcement that the combined portfolios will present a \"significant growth opportunity well into the next decade.\" The deal comes about a week after AbbVie announced it was acquiring cancer drugmaker ImmunoGen (IMGN) for just over $10 billion. Yahoo Finance Healthcare Reporter Anjalee Khemlani breaks down the deal.  For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.","url":"https://finance.yahoo.com/video/abbvie-acquiring-cerevel-therapeutics-8-150445627.html"},{"category":"company","date":1701956220,"headline":"JetBlue Airways, Semtech rise; Duckhorn, Chewy fall, Thursday, 12/7/2023","id":124365172,"image":"","symbol":"CERE","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=t2qqn68dl1"},{"category":"company","date":1701951300,"headline":"Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":124364215,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246254507"},{"category":"company","date":1701947760,"headline":"Cautious Hold Rating on Cerevel Amidst Acquisition by AbbVie","id":124365174,"image":"","symbol":"CERE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246170157"},{"category":"company","date":1701947340,"headline":"Cerevel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright","id":124365175,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246159153"},{"category":"company","date":1701946860,"headline":"After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next","id":124364696,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246149346"},{"category":"company","date":1701946680,"headline":"What You Missed On Wall Street This Morning","id":124364237,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246143362"},{"category":"company","date":1701941400,"headline":"Why Is Cyngn (CYN) Stock Up 73% Today?","id":124362148,"image":"","symbol":"CERE","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246022796"},{"category":"company","date":1701940740,"headline":"Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday","id":124360579,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246010563"},{"category":"company","date":1701940200,"headline":"LILM Stock Alert: Lilium Partners Up With Lufthansa","id":124362149,"image":"","symbol":"CERE","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245996843"},{"category":"company","date":1701939840,"headline":"Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more","id":124360036,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245990097"},{"category":"company","date":1701938820,"headline":"Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?","id":124364702,"image":"","symbol":"CERE","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245967970"},{"category":"company","date":1701935520,"headline":"AbbVie – Cerevel M\u0026A deal lifts Reviva, Karuna","id":124361248,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245898505"},{"category":"company","date":1701934140,"headline":"VTGN, CERE and RVPH are among pre market gainers","id":124360278,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245870544"},{"category":"company","date":1701933060,"headline":"Analysts Are Bullish on Top Healthcare Stocks: Neurosense Therapeutics Ltd. (NRSN), Cerevel Therapeutics Holdings (CERE)","id":124365187,"image":"","symbol":"CERE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245851150"},{"category":"company","date":1701933000,"headline":"12 Health Care Stocks Moving In Thursday's Pre-Market Session","id":124359976,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245850287"},{"category":"company","date":1701932700,"headline":"Why Cerevel Therapeutics Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket","id":124360175,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245845429"},{"category":"company","date":1701931380,"headline":"Datadog To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Thursday","id":124360583,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245821036"},{"category":"company","date":1701930780,"headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday","id":124360064,"image":"","symbol":"CERE","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245810904"},{"category":"company","date":1701929040,"headline":"Where Cerevel Therapeutics Hldg Stands With Analysts","id":124365192,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245782281"},{"category":"company","date":1701927840,"headline":"There’s a new market dynamic heading into payrolls report, Goldman trading expert says","id":124364706,"image":"","symbol":"CERE","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245761927"},{"category":"company","date":1701922560,"headline":"Cerevel Therapeutics downgraded to Neutral from Overweight at Piper Sandler","id":124365194,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245688538"},{"category":"company","date":1701922380,"headline":"Cerevel Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald","id":124364710,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245685064"},{"category":"company","date":1701921780,"headline":"Biggest stock movers today: GameStop, C3.AI, Chewy and more","id":124362053,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245677793"},{"category":"company","date":1701921060,"headline":"Analysts Conflicted on These Healthcare Names: Bioventus (BVS), Cerevel Therapeutics Holdings (CERE) and VistaGen Therapeutics (VTGN)","id":124365197,"image":"","symbol":"CERE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245668254"},{"category":"company","date":1701920760,"headline":"Hold Rating on Cerevel Amid Acquisition by AbbVie Reflects Pipeline Potential and Market Risks","id":124365198,"image":"","symbol":"CERE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245664860"},{"category":"company","date":1701916680,"headline":"M \u0026 A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B","id":124364712,"image":"","symbol":"CERE","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245613658"},{"category":"company","date":1701911460,"headline":"Stock market today: Wall Street gains ground ahead of a highly anticipated jobs report","id":124364254,"image":"","symbol":"CERE","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=hvlyw2qh9r"},{"category":"company","date":1701906783,"headline":"Shareholder Alert : Ademi LLP investigates whether Cerevel Therapeutics has obtained a Fair Price in its transaction with AbbVie","id":124352391,"image":"","symbol":"CERE","publisher":"Finnhub","summary":"MILWAUKEE, Dec. 6, 2023 /PRNewswire/ -- Ademi LLP is investigating Cerevel for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie. ...","url":"https://finnhub.io/api/news?id=27ffa2f516dd936f5b38d7799267d6672dc0ee4df10eb6c0a58aa0ea97758937"},{"category":"company","date":1701905104,"headline":"CERE MERGER ANNOUNCEMENT : Julie \u0026 Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics","id":124352156,"image":"","symbol":"CERE","publisher":"Finnhub","summary":"NEW YORK, Dec. 6, 2023 /PRNewswire/ -- Julie \u0026 Holleman LLP, a nationally recognized shareholder rights law firm, is investigating the proposed $45 per share sale of Cerevel Therapeutics Holdings,...","url":"https://finnhub.io/api/news?id=49c9af1e9648f4183d017f0b055eda106c3671c664920246674da5b04767f02b"},{"category":"company","date":1701899160,"headline":"AbbVie to Buy Cerevel Therapeutics for $8.7 Billion","id":124351959,"image":"https://s.yimg.com/ny/api/res/1.2/k3ntHvEV_XOLwBeBB21k1Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/d6065efef39c9862c53eeb97a18f4521","symbol":"CERE","publisher":"Yahoo","summary":"AbbVie will acquire neuroscience-drug maker Cerevel Therapeutics Holdings for $45 a share, giving the company an equity value of about $8.7 billion.","url":"https://finance.yahoo.com/m/755cb3c0-6c8e-3497-b039-ed851a5af794/abbvie-to-buy-cerevel.html"},{"category":"company","date":1701898200,"headline":"AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline","id":124351961,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"CERE","publisher":"Yahoo","summary":"AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) today announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson's disease (PD), and mood disorders. The acquisition complements AbbVie's neuroscience portfolio, adding a wide range of potentially best-in-class assets that may transform standa","url":"https://finance.yahoo.com/news/abbvie-acquire-cerevel-therapeutics-transformative-213000212.html"},{"category":"company","date":1701891242,"headline":"CERE Stock Alert : Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders","id":124348320,"image":"","symbol":"CERE","publisher":"Finnhub","summary":"Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cerevel Therapeutics Holdings, Inc. to AbbVie Inc. for $45.00 per share in cash is fair to Cerevel...","url":"https://finnhub.io/api/news?id=b933675ec2636822a8aa4709815d476d26f6d9d2acd4964e8af068de9cea3517"},{"category":"company","date":1701871540,"headline":"Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines","id":124338399,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1469261051/image_1469261051.jpg?io=getty-c-w1536","symbol":"CERE","publisher":"SeekingAlpha","summary":"Cerevel Therapeutics stock has surged over 250% since its Nasdaq listing and is set to discuss its Parkinson's drug Tavapadon. Learn more on CERE stock here.","url":"https://seekingalpha.com/article/4656384-cerevel-stock-soars-parkinsons-drug-update-rating-hold"},{"category":"company","date":1701844080,"headline":"Fly Intel: After-Hours Movers","id":124349081,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244977631"},{"category":"company","date":1701835260,"headline":"AbbVie to buy Cerevel Therapeutics in $8.7 billion all-cash deal","id":124364716,"image":"","symbol":"CERE","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244726622"},{"category":"company","date":1701835200,"headline":"Cerevel Therapeutics trading resumes","id":124365204,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244726216"},{"category":"company","date":1701834600,"headline":"Cerevel Therapeutics jumps after AbbVie agrees to $8.7B takeover (update)","id":124364717,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244707624"},{"category":"company","date":1701833760,"headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session","id":124344289,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244684972"},{"category":"company","date":1701833580,"headline":"AbbVie to acquire Cerevel Therapeutics for $45.00 per share in cash, or $8.7B","id":124364720,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244680415"},{"category":"company","date":1701833460,"headline":"AbbVie to acquire Cerevel Therapeutics for $45.00 per share in cash","id":124364721,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244677479"},{"category":"company","date":1701833340,"headline":"Cerevel Therapeutics trading halted, news pending","id":124365214,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244671761"},{"category":"company","date":1701832140,"headline":"Cerevel Therapeutics jumps on report of Abbvie nearing $8B takeover","id":124364723,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244639485"},{"category":"company","date":1701832080,"headline":"Cerevel Therapeutics up 16% after Reuters report on AbbVie deal talks","id":124364724,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244638924"},{"category":"company","date":1701831900,"headline":"AbbVie near deal to buy Cerevel for about $45 per share, Reuters says","id":124364725,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244634735"},{"category":"company","date":1701831840,"headline":"AbbVie near about $8B deal to buy Cerevel Therapeutics, Reuters reports","id":124364726,"image":"","symbol":"CERE","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244633344"},{"category":"company","date":1701776160,"headline":"12 Health Care Stocks Moving In Tuesday's Intraday Session","id":124308389,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242459041"},{"category":"company","date":1701767220,"headline":"NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday","id":124304024,"image":"","symbol":"CERE","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242260904"},{"category":"company","date":1701651720,"headline":"CERE Crosses Above Key Moving Average Level","id":124308391,"image":"","symbol":"CERE","publisher":"Market News Video","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240832090"},{"category":"company","date":1701257400,"headline":"Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s Disease","id":124185484,"image":"https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","symbol":"CERE","publisher":"Yahoo","summary":"Event will focus on tavapadon, a D1/D5 partial agonist in Phase 3 development for the treatment of Parkinson’s disease Live webcast scheduled for Monday, December 11 from 10:00 to 11:30 a.m. ET CAMBRIDGE, Mass., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced it will host a tavapadon investor webcast on Monday, December 11, from 10:00 to 11:30 a.m. ET. Cerevel will lead a","url":"https://finance.yahoo.com/news/cerevel-therapeutics-host-investor-webcast-113000755.html"},{"category":"company","date":1700883300,"headline":"JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower","id":124112549,"image":"","symbol":"CERE","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3228401750"}]}